ID   DLD-1 SLC2A1(-/-)
AC   CVCL_HD63
SY   GLUT1 (-/-) DLD-1
DR   Horizon_Discovery; HD+R00-024
DR   Wikidata; Q54831165
RX   PubMed=19661383;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11005; SLC2A1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
RX   PubMed=19661383; DOI=10.1126/science.1174229; PMCID=PMC2820374;
RA   Yun J., Rago C., Cheong I., Pagliarini R., Angenendt P.,
RA   Rajagopalan H., Schmidt K., Willson J.K.V., Markowitz S.D., Zhou S.-B.,
RA   Diaz L.A. Jr., Velculescu V.E., Lengauer C., Kinzler K.W.,
RA   Vogelstein B., Papadopoulos N.;
RT   "Glucose deprivation contributes to the development of KRAS pathway
RT   mutations in tumor cells.";
RL   Science 325:1555-1559(2009).
//